Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Department of Biochemistry and Molecular Biology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Front Immunol. 2022 Nov 2;13:1020574. doi: 10.3389/fimmu.2022.1020574. eCollection 2022.
Manuka honey (MH) is known for its wound-healing, anti-microbial, anti-oxidant and anti-tumor properties. However, there is conflicting evidence regarding the role of MH in inflammatory responses, with some studies highlighting its pro-inflammatory capacity and others showing that it has a predominantly anti-inflammatory activity. The current study is aimed at characterizing the immunomodulatory capacity of MH using both and approaches, focusing on the underlying mechanisms. Treatment of RAW 264.7 macrophages with 1% MH (w/v) resulted in a significant increase in the gene expression (26-fold) and secretion (27-fold) of tumor necrosis factor-alpha (TNF-α). Similarly, an increase was observed in the gene expression of other inflammatory cytokines including interleukin-1β (, interleukin-6 (), and inducible nitric oxide synthase (i), as well as the chemokines; (C-X-C motif) ligand 2 () and (C-C) motif ligand 2 (). Using an model, intraperitoneal (i.p.) administration of MH in C57BL/6 mice elicited a peritoneal response characterized by a significant expansion in the number of peritoneal exudate cells (PECs), which was mainly due to a 35-fold increase in the recruitment of neutrophils. Importantly, this response was evident in toll-like receptor 4 (TLR4)-defective C3H/HeJ mice, indicating that the observed stimulatory effect occurs independently of TLR4 and unlikely to be mediated by any lipopolysaccharide (LPS) contaminant. MH administration also led to changes in the phenotypic expression and functional maturation of peritoneal macrophages, as evidenced by a shift towards the CD11b F4/80 phenotype and an increase in the expression of major histocompatibility complex (MHC) class II proteins. In contrast, the MH-initiated peritoneal response was largely abrogated in mice deficient in myeloid differentiation primary response 88 (MyD88) protein, a critical adaptor of most TLR signaling pathways. Thus, the current findings help to characterize the immunostimulatory properties of MH and their dependence on TLR signaling, and highlight the potential utility of MH as an immunomodulatory agent in a variety of disorders.
麦卢卡蜂蜜(MH)以其伤口愈合、抗微生物、抗氧化和抗肿瘤特性而闻名。然而,关于 MH 在炎症反应中的作用存在相互矛盾的证据,一些研究强调其促炎能力,而另一些研究表明其具有主要的抗炎活性。本研究旨在使用和方法表征 MH 的免疫调节能力,重点研究潜在机制。用 1% MH(w/v)处理 RAW 264.7 巨噬细胞可显著增加肿瘤坏死因子-α(TNF-α)的基因表达(26 倍)和分泌(27 倍)。同样,观察到其他炎症细胞因子的基因表达增加,包括白细胞介素-1β(,白细胞介素-6()和诱导型一氧化氮合酶(i),以及趋化因子;(C-X-C 基序)配体 2 () 和 (C-C) 基序配体 2 ()。使用体内模型,MH 在 C57BL/6 小鼠中的腹腔内(i.p.)给药引起腹腔反应,其特征在于腹腔渗出细胞(PECs)数量显著增加,这主要是由于中性粒细胞募集增加了 35 倍。重要的是,这种反应在 Toll 样受体 4(TLR4)缺陷型 C3H/HeJ 小鼠中是明显的,表明观察到的刺激作用独立于 TLR4,不太可能由任何脂多糖(LPS)污染物介导。MH 给药还导致腹腔巨噬细胞表型表达和功能成熟发生变化,表现在 CD11b F4/80 表型向 CD11b F4/80 表型的转变和主要组织相容性复合体(MHC)II 类蛋白表达增加。相比之下,在缺乏髓样分化初级反应 88(MyD88)蛋白的小鼠中,MH 引发的腹腔反应在很大程度上被消除,MyD88 蛋白是大多数 TLR 信号通路的关键衔接蛋白。因此,目前的研究结果有助于表征 MH 的免疫刺激特性及其对 TLR 信号的依赖性,并强调 MH 作为各种疾病的免疫调节剂的潜在用途。